The Duke University Health System was responsible for the second-ever utilization of a technology that acts as a complete artificial heart to extend the lives of patients waiting for a transplant. The BiVACOR Total Artificial Heart, a device currently undergoing clinical trials, was used in August to keep Donavan Harbison,…